New Delhi: RFCL Ltd, an ICICI Venture company, has made its first global acquisition in the space of veterinary health care through a share purchase agreement with Marsung & Co Ltd A/S for its Germany-based subsidiary Bremer Pharma GmbH. Bremer Pharma has 803 global registrations across Europe, West Asia, Asia and Africa. The agreement is for transfer of all key people, assets, brands, all contracts including exports. The acquisition follows the buyout of Alved in January. RFCL''s animal healthcare business under Vetnes is expected to achieve a turnover of Rs 90 crore for 2008. Combined with sales revenue of Bremer Pharma and Alved, RFCL''s veterinary product portfolio will be in excess of Rs 160 crore.
Subscribe to:
Post Comments (Atom)
No comments:
Post a Comment